L. González-Méndez

The kinesin spindle protein inhibitor filanesib enhances the activity of pomalidomide and dexamethasone in multiple myeloma

B. Tunquist, E. Dı́az-Rodrı́guez, T. Paíno, 2017, Haematologica.

Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair

P. L. Bergsagel, M. González-Díaz, T. Paíno, 2017, Journal of Hematology & Oncology.

Synergistic DNA-damaging effect in multiple myeloma with the combination of zalypsis, bortezomib and dexamethasone

T. Paíno, L. San-Segundo, S. Hernández-García, 2017, Haematologica.

Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma

T. Paíno, L. San-Segundo, S. Hernández-García, 2020, Cancers.

The Novel Pan-PIM Kinase Inhibitor, PIM447, Displays Dual Antimyeloma and Bone-Protective Effects, and Potently Synergizes with Current Standards of Care

Carlos Ortiz-de-Solorzano, Antonio Garcia-Gomez, T. Paíno, 2016, Clinical Cancer Research.